Ranolazine in Chronic Total Occlusion Percutaneous Coronary Intervention
Journal of Invasive Cardiology · 2024
DOI: 10.25270/jic/24.00059 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Invasive Cardiology, 2024. Verfasst von Michaella Alexandrou und 26 weiteren Autor:innen. Beteiligte Einrichtung: Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA. Hauptthemen laut MEDLINE: Ranolazine, Percutaneous Coronary Intervention, Coronary Occlusion, Registries.
Abstract (Originalsprache)
Ranolazine is an anti-anginal medication given to patients with chronic angina and persistent symptoms despite medical therapy. We examined 11 491 chronic total occlusion (CTO) percutaneous coronary interventions (PCI) that were performed at 41 US and non-US centers between 2012 and 2023 in the PROGRESS-CTO Registry. Patients on ranolazine at baseline had more comorbidities, more complex lesions, lower procedural and technical success (based on univariable but not multivariable analysis), and higher incidence of major adverse cardiac events (MACE) (on both univariable and multivariable analysis).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.
- Texas Health Presbyterian Hospital, Dallas, Texas, USA; Baylor Scott and White Heart and Vascular Hospital, Dallas, Texas, USA.
- University Hospitals, Case Western Reserve University, Cleveland, Ohio, USA.
- Henry Ford Cardiovascular Division, Detroit, Michigan, USA.
- WellSpan York Hospital, York, Pennsylvania, USA.
- Massachusetts General Hospital, Boston, Massachusetts, USA.
Zitieren
APA
Alexandrou, M., Mutlu, D., Rempakos, A., Al Ogaili, A., Choi, J. W., Poommipanit, P., Alaswad, K., Basir, M. B., Davies, R., Jaffer, F. A., Dattilo, P., Azzalini, L., Aygul, N., Reddy, N., Jefferson, B. K., Gorgulu, S., Khatri, J. J., Young, L. D., Krestyaninov, O., …, & Brilakis, E. S. (2024). Ranolazine in Chronic Total Occlusion Percutaneous Coronary Intervention. Journal of Invasive Cardiology. https://doi.org/10.25270/jic/24.00059
Vancouver
Alexandrou M, Mutlu D, Rempakos A, Al Ogaili A, Choi JW, Poommipanit P, et al. Ranolazine in Chronic Total Occlusion Percutaneous Coronary Intervention. Journal of Invasive Cardiology. 2024. doi:10.25270/jic/24.00059
BibTeX
@article{Alexandrou2024,
author = {Alexandrou, Michaella and Mutlu, Deniz and Rempakos, Athanasios and Al Ogaili, Ahmed and Choi, James W and Poommipanit, Paul and Alaswad, Khaldoon and Basir, Mir Babar and Davies, Rhian and Jaffer, Farouc A and Dattilo, Phil and Azzalini, Lorenzo and Aygul, Nazif and Reddy, Niranjan and Jefferson, Brian K and Gorgulu, Sevket and Khatri, Jaikirshan J and Young, Laura D and Krestyaninov, Oleg and Khelimskii, Dmitrii and Frizzell, Jarrod and Elbarouni, Basem and Rangan, Bavana V and Mastrodemos, Olga C and Burke, M Nicholas and Sandoval, Yader and Brilakis, Emmanouil S},
title = {Ranolazine in Chronic Total Occlusion Percutaneous Coronary Intervention},
journal = {Journal of Invasive Cardiology},
year = {2024},
doi = {10.25270/jic/24.00059}
}
EUVIMED